Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,112 | 70 | 98.9% |
| Education | $11.90 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $244.34 | 12 | $0 (2024) |
| ABBVIE INC. | $238.04 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $117.02 | 7 | $0 (2023) |
| Abbott Laboratories | $101.56 | 7 | $0 (2023) |
| Astellas Pharma US Inc | $92.13 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $85.24 | 6 | $0 (2022) |
| Medtronic, Inc. | $44.07 | 2 | $0 (2022) |
| Acella Pharmaceuticals, LLC | $32.01 | 2 | $0 (2019) |
| Dexcom, Inc. | $31.34 | 2 | $0 (2023) |
| Eisai Inc. | $25.15 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $271.32 | 13 | Novartis Pharmaceuticals Corporation ($216.68) |
| 2023 | $194.25 | 13 | AbbVie Inc. ($142.44) |
| 2022 | $127.11 | 7 | Medtronic, Inc. ($44.07) |
| 2021 | $98.55 | 7 | Janssen Biotech, Inc. ($28.09) |
| 2020 | $122.33 | 9 | Astellas Pharma US Inc ($40.51) |
| 2019 | $122.81 | 8 | Astellas Pharma US Inc ($23.29) |
| 2018 | $73.74 | 6 | AbbVie, Inc. ($13.24) |
| 2017 | $113.97 | 8 | Abbott Laboratories ($73.74) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Dermatology | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Dermatology | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Dermatology | ||||||
| 08/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Dermatology | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Dermatology | ||||||
| 06/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Dermatology | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Dermatology | ||||||
| 05/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Dermatology | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: Dermatology | ||||||
| 04/11/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Biological | ||||||
| 12/20/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.84 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: VACCINES | ||||||
| 09/13/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Endocrinology | ||||||
| 08/18/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: IMMUNOLOGY | ||||||
| 06/23/2023 | AbbVie Inc. | SYNTHROID (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: IMMUNOLOGY | ||||||
| 05/26/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Neuromodulation | ||||||
| 04/25/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: NEUROSCIENCE | ||||||
| 02/03/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 652 | 3,574 | $284,657 | $98,857 |
| 2022 | 17 | 869 | 3,042 | $271,926 | $86,037 |
| 2021 | 21 | 1,482 | 3,833 | $317,971 | $92,715 |
| 2020 | 23 | 1,590 | 3,720 | $297,307 | $79,102 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 27 | 2,700 | $102,600 | $49,431 | 48.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 234 | 373 | $110,408 | $31,657 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 115 | $25,070 | $6,283 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $16,380 | $4,505 | 27.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 116 | 175 | $12,075 | $1,650 | 13.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 21 | 21 | $1,974 | $1,511 | 76.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $4,350 | $1,011 | 23.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 31 | 39 | $2,145 | $972.36 | 45.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $700.00 | $641.74 | 91.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 48 | $2,880 | $509.76 | 17.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 12 | 12 | $4,800 | $425.52 | 8.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 15 | $1,275 | $259.50 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 238 | 410 | $121,360 | $34,996 | 28.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 21 | 1,860 | $70,680 | $31,282 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 152 | $33,136 | $8,522 | 25.7% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 37 | 37 | $2,775 | $2,533 | 91.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 138 | 224 | $15,456 | $2,125 | 13.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $8,400 | $2,049 | 24.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 24 | 43 | $2,365 | $1,079 | 45.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 37 | 37 | $1,030 | $981.34 | 95.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 46 | 47 | $3,549 | $788.58 | 22.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 12 | 12 | $4,800 | $420.36 | 8.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 23 | 35 | $2,100 | $382.77 | 18.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 81 | 92 | $1,702 | $275.70 | 16.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 27 | 27 | $1,755 | $228.42 | 13.0% |
About Dr. Bindubal Balan, M.D
Dr. Bindubal Balan, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093890287.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bindubal Balan, M.D has received a total of $1,124 in payments from pharmaceutical and medical device companies, with $271.32 received in 2024. These payments were reported across 71 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,112).
As a Medicare-enrolled provider, Balan has provided services to 4,593 Medicare beneficiaries, totaling 14,169 services with total Medicare billing of $356,712. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Greensboro, NC
- Active Since 10/26/2006
- Last Updated 02/11/2010
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1093890287
Products in Payments
- COSENTYX (Drug) $216.68
- FreeStyle Libre Pro (Device) $86.75
- MYRBETRIQ (Drug) $78.51
- SHINGRIX (Biological) $73.22
- UBRELVY (Drug) $62.66
- SKYRIZI (Biological) $47.34
- INTELLIS ADAPTIVESTIM (Device) $44.07
- SYNTHROID (Drug) $43.69
- SIMPONI ARIA (Biological) $42.20
- QULIPTA (Drug) $33.65
- NP Thyroid (Drug) $32.01
- Dexcom G6 Transmitter (Medical Supply) $31.34
- TREMFYA (Drug) $29.11
- COSENTYX (Biological) $27.66
- RINVOQ (Biological) $25.55
- GENERAL PAIN MANAGEMENT (Device) $20.72
- TRELEGY ELLIPTA (Drug) $16.87
- Zio monitor (Device) $15.47
- ORENCIA (Biological) $15.26
- PROCLAIM (Device) $14.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Greensboro
Stephen South, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $875,621
Walter Kohut, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $17,473
Dr. Ajay Kumar, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $7,072
Dr. Cristina Gherghe, Md, Phd, MD, PHD
Endocrinology, Diabetes & Metabolism — Payments: $3,307
Sudan Thapa, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,987
Komal Motwani
Endocrinology, Diabetes & Metabolism — Payments: $1,683